Journal: Scientific Reports
Article Title: The ammonia oxidizing bacterium Nitrosomonas eutropha blocks T helper 2 cell polarization via the anti-inflammatory cytokine IL-10
doi: 10.1038/s41598-021-93299-1
Figure Lengend Snippet: AOB-mediated Th2 inhibition requires IL-10 and is associated with a suppression of dendritic cell activity. ( a – d ) Expression of MHC II ( a , b ) or CD86 ( c , d ) in CD11c+ cells is reduced in PBMC treated with AOB prior to Th2 differentiation cocktail stimulation; measured by flow cytometry in Th2-stimulated PBMC in the presence or absence of AOB. ( a , c ) Representative fluorescence intensity plots of anti-MHC II FITC ( a ) or anti-CD86 PE ( c ) stained PBMC from donor C in the presence (red) or absence (grey) of AOB. ( b , d ) Relative MHC II ( b ) or CD86 ( d ) expression in CD11c+ positive cells is reduced with AOB treatment in 3 donors (n = 3 per donor, unpaired t-test, p < 0.0001 for MHC II and CD86 aggregated donor datasets). ( e ) IL-10 production is induced by AOB in PBMC from 3 donors 24 h post-stimulation; measured by ELISA of culture supernatants (n = 3 per donor, p = 0.1095 for aggregated donor data set). ( f – h ) Addition of IL-10 neutralizing antibodies to PBMC prior to AOB pretreatment interfered with AOB’s inhibition of Th2. IL-10 ( f ) production by Th2-stimulated PBMC was reduced with the addition of IL-10 neutralizing antibody but not with isotype control in 3 donors (n = 3 per donor, one point per donor, one-way ANOVA with multiple comparisons). AOB-mediated fold reduction in IL-5 ( g ) was obstructed by the addition of IL-10 neutralizing antibody compared to isotype control in 2 of 3 donors tested (n = 3 per donor, unpaired t test). AOB-mediated reduction in CD86 expression ( h ) in CD11c+ cells is hindered with the addition of IL-10 neutralizing antibody but not with isotype control (n = 3, donor D, one-way ANOVA with multiple comparisons).
Article Snippet: PBMC were then stimulated using either the CellXvivo human Th2 differentiation kit (R&D systems) following the manufacturer’s recommendations, or 1 μg/mL SEB (Sigma).
Techniques: Inhibition, Activity Assay, Expressing, Flow Cytometry, Fluorescence, Staining, Enzyme-linked Immunosorbent Assay, Control